Literature DB >> 12629279

Laterality of brain tumors.

Peter D Inskip1, Robert E Tarone, Elizabeth E Hatch, Timothy C Wilcosky, Robert G Selker, Howard A Fine, Peter McL Black, Jay S Loeffler, William R Shapiro, Martha S Linet.   

Abstract

Tumor laterality was evaluated with respect to presenting symptoms and demographic factors among 489 adults with histologically confirmed glioma (354 high-grade, 135 low-grade), 197 with meningioma, and 96 with acoustic neuroma. The ratio of left-sided to right-sided tumors did not differ significantly from 1.00 for any of the major tumor types. Low-grade glioma and meningioma occurred nonsignificantly more often on the left side, whereas high-grade glioma and acoustic neuroma occurred nonsignificantly more often on the right side. Aphasia or mental status changes were significantly more common among glioma patients with tumors on the left side than among those with tumors on the right side. Associations between tumor laterality and symptoms may influence the probability or timing of diagnosis, possibly differentially by marital status. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12629279     DOI: 10.1159/000068747

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  3 in total

1.  Assessment of vascularity in glioblastoma and its implications on patient outcomes.

Authors:  Ben G McGahan; Beth K Neilsen; David L Kelly; Rodney D McComb; S A Jaffar Kazmi; Matt L White; Yan Zhang; Michele R Aizenberg
Journal:  J Neurooncol       Date:  2017-01-19       Impact factor: 4.130

2.  Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation.

Authors:  Claudia Baumann; Julia Tichy; Jan Hendrik Schaefer; Joachim P Steinbach; Michel Mittelbronn; Marlies Wagner; Christian Foerch
Journal:  J Neurooncol       Date:  2019-11-11       Impact factor: 4.130

3.  Incidence of gliomas by anatomic location.

Authors:  Suvi Larjavaara; Riitta Mäntylä; Tiina Salminen; Hannu Haapasalo; Jani Raitanen; Juha Jääskeläinen; Anssi Auvinen
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.